A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06223646 · UNKNOWN
Trial details
- NCT number
- NCT06223646
- Sponsor
- Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-11
- Primary completion
- 2026-03-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.